Glaucoma is a complex and progressive disease that primarily affects the optic nerve axons,
leading to irreversible vision loss. Although the exact molecular mechanisms underlying …

While preclinical efforts continue in several laboratories, an increasing number of start-up
and large pharmaceutical companies are working on developing gene therapeutics for …

Introduction Glaucoma is the most common optic neuropathy and the leading cause of
irreversible blindness worldwide, which affects 3.54% of the population aged 40–80 years …

Este estudo examina estratégias promissoras no desenvolvimento de novas terapias para o
tratamento do glaucoma, adotando uma perspectiva integrativa e inovadora. Inicialmente …

Terri Pickering, MD, clinical instructor, California Pacific Medical Center, and board of
directors member, Glaucoma Research Foundation, San Francisco, reported that there is …